CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.
about
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
CRISPR/Cas9 Mediated Disruptio ...... rly-Onset Alzheimer's Disease.
@en
CRISPR/Cas9 Mediated Disruptio ...... rly-Onset Alzheimer's Disease.
@nl
type
label
CRISPR/Cas9 Mediated Disruptio ...... rly-Onset Alzheimer's Disease.
@en
CRISPR/Cas9 Mediated Disruptio ...... rly-Onset Alzheimer's Disease.
@nl
prefLabel
CRISPR/Cas9 Mediated Disruptio ...... rly-Onset Alzheimer's Disease.
@en
CRISPR/Cas9 Mediated Disruptio ...... rly-Onset Alzheimer's Disease.
@nl
P2093
P2860
P921
P1476
CRISPR/Cas9 Mediated Disruptio ...... rly-Onset Alzheimer's Disease.
@en
P2093
Adrienn Volak
Bence György
Benjamin P Kleinstiver
Caitlin Commins
Camilla Lööv
Casey A Maguire
J Keith Joung
Ksenia Kastanenka
Lars Lannfelt
P2860
P304
P356
10.1016/J.OMTN.2018.03.007
P577
2018-03-16T00:00:00Z